Spectrum, Prevalence, and Clinical Correlates of PPM1D Mutations in Patients with Clonal Haematopoiesis and Clonal Cytopenias
Talha Badar(Mayo Clinic in Florida), Mrinal M. Patnaik(Mayo Clinic), Abhishek A. Mangaonkar(Mayo Clinic), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Francyess Denis Oliva(Duke University), Mithun Vinod Shah(Mayo Clinic in Arizona), Ludovica Marando(Wellcome/MRC Cambridge Stem Cell Institute), Omer Jamy(University of Alabama at Birmingham Hospital), James M. Foran(Memorial Sloan Kettering Cancer Center), Anand Patel(Ascension), Kendall Diebold(University of Alabama at Birmingham), Terra Lasho(Mayo Clinic), Liuyan Jiang(Jacksonville College), Kristina Kirschner(Mayo Clinic), Benjamin J. McCormick(Jacksonville College), Yael Kusne(WinnMed), Chenyu Lin(Duke University), Alexander Coltoff(Columbia University Irving Medical Center), Christy M. Finke(Mayo Clinic), Rong He(Mayo Clinic), Mobachir El Kettani(Jacksonville College), Mark R. Litzow(Dana-Farber Cancer Institute), Yao‐Shan Fan(Jacksonville College), David S. Viswanatha(Mayo Clinic), Antoine N. Saliba(Mayo Clinic in Arizona), Thomas J. Miles(University of Illinois Chicago), Aref Al‐Kali(Mayo Clinic)
Cited by 1
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396